Skip to product information
  • Bulletin of the IDF N° 377/2002 - Health benefits and safety evaluation of certain food components - FIL-IDF
1 of 1

Bulletin of the IDF N° 377/2002 - Health benefits and safety evaluation of certain food components

Regular price FREE
Regular price Sale price €0,00
Sale Sold out
Type
Language

Document info

pages 42
published date 24 March 2002
reference Bulletin of the IDF No. 377/2002

Publication description

Health benefits and safety evaluation of certain food components
Food microorganisms - health benefits, safety evaluation and strains with documented history of use in foods
G. Mogensen, S. Salminen, J. O’Brien, A. Ouwehand, W. Holzapfel, C. Shortt, R. Fondén,G.D. Miller, D. Donohue, M. Playne, R. Crittenden & B. Bianchi Salvadori

This scientific summary reviews the latest research related to health benefits and safety evaluation of lactic acid bacteria (LAB) and introduces an inventory of food microorganism species with a history of safe use in foods.
6 pp

Inventory of Microorganisms with a documented history of use in food
J. Seifert & G. Mogensen

In order to classify traditionally used microorganisms (starter cultures) as safe food ingredients, the IDF in collaboration with EFFCA (European Food and Fed Cultures Association) has compiled an inventory of microorganisms with a documented history of use in food. The inventory is contained in full in this paper.
10 pp

Trans Fatty Acids
Y. Soustre, B. Laurent, J. Schrezenmeir, M. Pfeuffer, G. Miller & P. Parodi

The expression ‘trans fatty acids’ encompasses a large number of substances having highly heterogeneous roles. Several experimental and epidemiological studies suggest that trans fatty acids (mainly elaidic acid) would seem to have negative effects on plasma cholesterol levels and the incidence of cardiovascular disease, as described in this paper.
12pp

Milk lipids in diet and health – Medium Chain Fatty Acids (MCFA)
M. Pfeuffer & J. Schrezenmeir

Due to its unique absorption and metabolism characteristics, medium chain triglyceride (MCT) preparations have been used therapeutically since the 1950s, mostly for parenteral nutrition and in the treatment of long-chain triglyceride (LCT) malabsorption, or as concentrated source of energy for preterm infants. This paper looks at the potential role of MCFA/MCT on health and performance in an everyday setting and in modulating Western life style health risks.
11 pp

Stay up to date with all the latest IDF publications with one of our yearly packages

Save now